Torsades de pointes (pronounced tor-SAHD duh PWANT) is a specific type of abnormal heart rhythm where the heart’s lower chambers beat so fast and erratically that they can’t pump blood effectively. The name is French for “twisting of the points,” describing the distinctive pattern the rhythm creates on a heart monitor: the electrical signal appears to rotate around a central line, with peaks that rise and fall in a spiraling wave. It’s a medical emergency because it can stop on its own within seconds or deteriorate into cardiac arrest.
How It Differs From Other Heart Rhythms
Torsades de pointes falls under the broader category of ventricular tachycardia, meaning it originates in the heart’s lower pumping chambers and drives the heart rate dangerously fast. What makes it unique is its relationship to the QT interval, a measurement on an electrocardiogram (EKG) that reflects how long heart cells take to reset between beats. In torsades, the QT interval is abnormally prolonged before the arrhythmia starts, which is why the condition is sometimes described as a complication of long QT syndrome rather than a standalone diagnosis.
A QT interval corrected for heart rate (called QTc) above 500 milliseconds is considered dangerous for both men and women. Approximate thresholds for what’s abnormally prolonged are 470 ms for men and 480 ms for women. There’s no QTc value below which prolongation is guaranteed safe, but risk rises sharply once you cross the 500 ms mark.
What Happens Inside the Heart
The root problem is electrical. Heart cells normally fire, contract, and then reset in an orderly sequence. When the QT interval is prolonged, cells take too long to reset, and during that vulnerable window, small electrical glitches called early afterdepolarizations (EADs) can occur. These are abnormal voltage fluctuations that happen while the cell is still trying to recover from its previous beat. If the fluctuation is strong enough, it triggers a premature heartbeat.
That premature beat alone isn’t torsades. The arrhythmia takes off because prolonged QT intervals don’t affect every part of the heart equally. Some regions reset faster than others, creating patches of tissue in different electrical states. This patchwork means the premature beat’s electrical signal doesn’t travel in a straight line. Instead, it spirals through the heart in shifting, rotating patterns, producing the characteristic twisting appearance on the EKG. The early afterdepolarizations provide both the spark that starts the arrhythmia and the uneven electrical landscape that sustains it.
What It Feels Like
Short episodes lasting a few seconds may cause a sudden sensation of the heart racing, dizziness, or lightheadedness. Many people describe a feeling that something is suddenly wrong in their chest before the episode self-terminates. Longer episodes reduce blood flow to the brain, causing fainting (syncope), which is often the symptom that brings someone to medical attention. If the rhythm doesn’t stop on its own and degenerates into ventricular fibrillation, the person loses consciousness and has no pulse. Without treatment at that point, it is fatal.
Some people experience repeated short runs that stop and restart, causing episodes of fainting that come and go over minutes to hours. Others have a single sustained episode that rapidly becomes a cardiac arrest.
Medications That Can Trigger It
Drug-induced QT prolongation is the most common acquired cause. Several classes of medication carry this risk, and the list is long enough that a dedicated database (CredibleMeds) tracks and regularly updates it. The highest-risk categories include certain heart rhythm medications, some antibiotics, and several psychiatric drugs including certain antipsychotics and antidepressants. Some antihistamines and antifungal medications also appear on the list. Importantly, the evidence for each drug varies. Some have clear links to torsades itself, while others are known to prolong the QT interval without convincing proof that they actually trigger the arrhythmia.
The risk from any single medication increases substantially when combined with other risk factors. Research identifying predictors of dangerous QT prolongation in hospitalized patients found that taking one QT-prolonging drug roughly tripled the odds, but taking two or more such drugs simultaneously pushed the risk even higher. Other factors that compounded the danger included low potassium levels (below 3.5 mEq/L), a diagnosis of heart attack or sepsis, reduced heart function, being female, and being over age 68. Diuretics (water pills) added risk as well, likely because they lower potassium and magnesium levels.
Low Potassium and Magnesium
Electrolyte imbalances are a major trigger, particularly low potassium (hypokalemia) and low magnesium (hypomagnesemia). Both minerals are essential for the electrical channels in heart cells to function normally. When levels drop, those channels stay open longer than they should, directly prolonging the QT interval. Diuretics prescribed for heart failure or high blood pressure are a frequent culprit because they cause the kidneys to excrete more of both minerals. Prolonged vomiting, diarrhea, and heavy alcohol use can also deplete these electrolytes.
What makes this combination particularly dangerous is that low magnesium makes it harder for the body to correct low potassium. The two deficiencies reinforce each other. In reported cases, patients on a combination of heart medications and diuretics developed torsades when both potassium and magnesium fell to borderline-low levels, even when no single factor alone would have been expected to cause problems.
Congenital Long QT Syndrome
Some people are born with genetic mutations that prolong the QT interval from childhood. Three main types account for most cases, and they differ in surprising ways.
- Type 1 (LQT1): Triggered primarily by physical exertion and exercise. Swimming is a particularly notable trigger for this type.
- Type 2 (LQT2): Triggered by sudden startling events, especially loud or unexpected sounds like an alarm clock or a ringing phone.
- Type 3 (LQT3): Episodes occur most often during rest or sleep, which makes this type harder to predict and, in some ways, harder to protect against.
These different triggers reflect which specific ion channel in the heart is affected by the mutation. Knowing your type matters because it shapes which activities to modify and which treatments work best.
How It’s Treated in an Emergency
Intravenous magnesium is the first-line treatment for an active episode, even if the patient’s magnesium levels test normal. Magnesium helps stabilize the electrical channels in heart cells and suppress the afterdepolarizations that drive the arrhythmia. However, only a small fraction of a magnesium dose actually reaches heart tissue quickly after a single bolus, which is why the response isn’t always immediate.
If the arrhythmia has deteriorated into cardiac arrest, electrical defibrillation is used to reset the heart’s rhythm. For people with recurring episodes, temporary pacing of the heart at a faster rate can prevent the pauses between heartbeats that often set off torsades. This works because a faster baseline heart rate shortens the QT interval, closing the vulnerable window where afterdepolarizations form.
Equally important is identifying and removing the cause. If a medication triggered the episode, it’s stopped immediately. If low potassium or magnesium is the issue, aggressive replacement of both electrolytes is essential. For people with congenital long QT syndrome who survive an episode, an implantable defibrillator may be recommended to automatically shock the heart back into rhythm if torsades recurs.
Who Is at Highest Risk
Women are about 1.5 times more likely than men to develop dangerous QT prolongation, partly because their baseline QT intervals tend to be slightly longer after puberty. People with existing heart disease, particularly those who have had a heart attack or have weakened heart function, face roughly 2.5 times the risk. Sepsis (a severe infection affecting the whole body) nearly triples it. Older adults, especially those over 68 on multiple medications, are particularly vulnerable because they’re more likely to have several risk factors simultaneously: reduced kidney function that slows drug clearance, prescriptions for QT-prolonging medications, and electrolyte imbalances from diuretics or poor nutrition.
The single most practical takeaway is that torsades de pointes rarely results from one isolated factor. It typically emerges from a combination: a medication that stretches the QT interval, an electrolyte imbalance that stretches it further, and an underlying condition that makes the heart more electrically unstable. Recognizing these overlapping risks is what allows prevention.